Immunogenicity of inactivated seasonal influenza vaccine in adult and pediatric liver transplant recipients over two seasons

Microbiology and Immunology

Volumn 57, Issue 10, 2013, Pages 715-722

  Suzuki, Michio ^a   Torii, Yuka ^a   Kawada, Jun Ichi ^a   Kimura, Hiroshi ^a   Kamei, Hideya ^a   Onishi, Yasuharu ^a   Kaneko, Kenitiro ^a   Ando, Hisami ^a   Kiuchi, Tetsuya ^a   Ito, Yoshinori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunogenicity; Influenza vaccination; Liver transplantation

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; GRAFT RECIPIENT; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRESCHOOL CHILD; SCHOOL CHILD; SEASONAL INFLUENZA; SEASONAL VARIATION; SEROCONVERSION;

IMMUNOGENICITY; INFLUENZA VACCINATION; LIVER TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INCIDENCE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TRANSPLANTATION; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84885466312     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12086     Document Type: Article

References (27)

1. Gangappa S., Kokko K.E., Carlson L.M., Gourley T., Newell K.A., Pearson T.C., Ahmed R., Larsen C.P. (2008) Immune responsiveness and protective immunity after transplantation. Transpl Int 21: 293-303.
2. Apalsch A.M., Green M., Ledesma-Medina J., Nour B., Wald E.R. (1995) Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 20: 394-9.
3. Duchini A., Hendry R.M., Redfield D.C., Pockros P.J. (2000) Influenza infection in patients before and after liver transplantation. Liver Transpl 6: 531-42.
4. Kunisaki K.M., Janoff E.N. (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9: 493-504.
5. Kumar D., Michaels M.G., Morris M.I., Green M., Avery R.K., Liu C., Danziger-Isakov L., Stosor V., Estabrook M., Gantt S., Marr K.A., Martin S., Silveira F.P., Razonable R.R., Allen U.D., Levi M.E., Lyon G.M., Bell L.E., Huprikar S., Patel G., Gregg K.S., Pursell K., Helmersen D., Julian K.G., Shiley K., Bono B., Dharnidharka V.R., Alavi G., Kalpoe J.S., Shoham S., Reid G.E., Humar A. (2010) Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 10: 521-6.
6. Kumar D., Blumberg E.A., Danziger-Isakov L., Kotton C.N., Halasa N.B., Ison M.G., Avery R.K., Green M., Allen U.D., Edwards K.M., Miller G., Michaels M.G. (2011) Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transpl 11: 2020-30.
7. Burbach G., Bienzle U., Stark K., Rayes N., Neuhaus R., Serke S., Engelmann H., Kunzel W., Turk G., Neuhaus P. (1999) Influenza vaccination in liver transplant recipients. Transplantation 67: 753-5.
8. Soesman N.M., Rimmelzwaan G.F., Nieuwkoop N.J., Beyer W.E., Tilanus H.W., Kemmeren M.H., Metselaar H.J., De Man R.A., Osterhaus A.D. (2000) Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 61: 85-93.
9. Duchini A., Hendry R.M., Nyberg L.M., Viernes M.E., Pockros P.J. (2001) Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl 7: 311-3.
10. Gaeta G.B., Pariani E., Amendola A., Brancaccio G., Cuomo G., Stornaiuolo G., Zappa A., Zanetti A. (2009) Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine 27: 3373-5.
11. Mack D.R., Chartrand S.A., Ruby E.I., Antonson D.L., Shaw B.W., Jr., Heffron T.G. (1996) Influenza vaccination following liver transplantation in children. Liver Transpl 2: 431-7.
12. Madan R.P., Tan M., Fernandez-Sesma A., Moran T.M., Emre S., Campbell A., Herold B.C. (2008) A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infectious Dis 46: 712-8.
13. Hojsak I., Avitzur Y., Mor E., Shamir R., Haimi-Cohen Y., Zakay-Rones Z., Wolf D., Shapiro R. (2011) Antibody response to influenza vaccine in pediatric liver transplant recipients. Pediatr Infect Dis J 30: 491-4.
14. Gotoh K., Ito Y., Suzuki E., Kaneko K., Kiuchi T., Ando H., Kimura H. (2011) Effectiveness and safety of inactivated influenza vaccination in pediatric liver transplant recipients over three influenza seasons. Pediatr Transpl 15: 112-6.
15. Torii Y., Kimura H., Ochi N., Kaneko K., Ando H., Kiuchi T., Ito Y. (2011) Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Vaccine 29: 4187-9.
16. Diazgranados C.A., Denis M., Plotkin S. (2012) Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 31: 49-57.
17. Ochiai H., Shibata M., Kamimura K., Niwayama S. (1986) Evaluation of the efficacy of split-product trivalent A(H1N1), A(H3N2), and B influenza vaccines: reactogenicity, immunogenicity and persistence of antibodies following two doses of vaccines. Microbiolo Immunol 30: 1141-9.
18. Kunzel W., Glathe H., Engelmann H., Van Hoecke C. (1996) Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 14: 1108-10.
19. Song J.Y., Cheong H.J., Hwang I.S., Choi W.S., Jo Y.M., Park D.W., Cho G.J., Hwang T.G., Kim W.J. (2010) Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence. Vaccine 28: 3929-35.
20. Moran J.J.M., Rose W.E., Darga A.J., Rohde K.A., Hayney M.S. (2011) Persistence of influenza vaccine-induced antibodies in lung transplant patients between seasons. Transpl Infect Dis 13: 466-70.
21. Cordero E., Aydillo T.A., Perez-Ordonez A., Torre-Cisneros J., Lara R., Segura C., Gentil M.A., Gomez-Bravo M.A., Lage E., Pachon J., Perez-Romero P. (2012) Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients. Transplantation 93: 847-54.
22. Severson J.J., Richards K.R., Moran J.J., Hayney M.S. (2012) Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season. Hum Vac Immunother 8: 1850-3.
23. Keitel W.A., Atmar R.L., Cate T.R., Petersen N.J., Greenberg S.B., Ruben F., Couch R.B. (2006) Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Int Med 166: 1121-7.
24. Falsey A.R., Treanor J.J., Tornieporth N., Capellan J., Gorse G.J. (2009) Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 200: 172-80.
25. Mcelhaney J.E., Hooton J.W., Hooton N., Bleackley R.C. (2005) Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. Vaccine 23: 3294-300.
26. Gasparini R., Pozzi T., Montomoli E., Fragapane E., Senatore F., Minutello M., Podda A. (2001) Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. Eur J Epidemiol 17: 135-40.
27. Vesikari T., Knuf M., Wutzler P., Karvonen A., Kieninger-Baum D., Schmitt H.J., Baehner F., Borkowski A., Tsai T.F., Clemens R. (2011) Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 365: 1406-16.